1 2 Salmonella Typhimurium (S. Tm) evades the innate immune response by residing within host 3 phagocytes. To identify inhibitors of intracellular S. Tm growth, we performed parallel chemical 4 screens against S. Tm growing in macrophage-mimicking media and within macrophages. These 5 screens identified novel antibacterials, and revealed that antibiotics with limited Gram-negative 6 coverage are active against intracellular S. Tm. Screening of a S. Tm deletion library in the 7 presence of one compound, metergoline, revealed that outer membrane perturbation enhanced 8 activity in vitro. Combined with our observation of atypical cell surface characteristics of 9 intracellular S. Tm, our work indicates that the bacterial outer membrane is permeabilized within 10 macrophages. We show that metergoline targets the bacterial cytoplasmic membrane, and 11 prolongs animal survival during a systemic S. Tm infection. This work highlights the predictive 12 nature of intracellular screens for in vivo efficacy, and uncovers new aspects of bacterial 13 physiology of intracellular S. Tm. 14 15 16 17
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LPS modifications and maintenance (e.g rfc, pgm, rfaK, rfaH, rbK, rfaI, pgm) . Taken together, 110 these data suggest that compounds that target metabolism or the bacterial cell surface would be 111 effective against intracellular S. Tm. 112 113
Identification of small molecule inhibitors of intracellular S. Tm 114
To identify putative antimicrobials effective against intracellular S. Tm, we conducted 115 two parallel chemical screens with an annotated compound collection composed largely of 116 previously-approved drugs ( Supplementary Table 1 ). We screened S. Tm grown in (i), LPM and 117 (ii), RAW264.7 macrophages (Figure 2A ). The collection of 1600 chemicals used in these 118 screens includes ~250 known antibacterial compounds with defined targets in Gram-positive and 119 -negative bacteria. To perform the intracellular screen, we modified the standard gentamicin 120 protection assay used to measure bacterial replication in macrophages. Briefly, we measured 121 luminescence from a constitutively expressed luciferase reporter gene to enable in situ 122 estimations of intramacrophage bacterial viability ( Figure S1 ). Together, these high-throughput 123 screens identified 130 compounds with growth-inhibitory activity (Supplementary Dataset S3), 124 ~40% of which were effective against both macrophage-internalized bacteria and cells grown in 125
LPM. The overlap in hits between these screens was consistent with ~50% concordance between 126 our genetic screens in LPM and macrophages. 127 We next analyzed the potency of all 130 actives from the primary screen. Conditions 128 included S. Tm grown in LPM, RAW264.7 macrophages, as well as standard nutrient-rich 129
(cation-adjusted Mueller-Hinton Broth, MHB) and nutrient-poor (MOPS glucose minimal media, 130 MOPS) microbiological media. We also measured lactate dehydrogenase (LDH) release from 131 uninfected macrophages as a measure of toxicity and did not pursue compounds with toxicity 132 >25% (percentage relative to maximum LDH release, see Materials and Methods) ( Figure 2B , 133
Supplemental Dataset S4). Using a cutoff for minimum inhibitory concentration (MIC) of 6.25 134 µM, we eliminated compounds with activity in MHB, as these are least likely to be 135 intramacrophage-selective in vivo. We found that nucleoside analogs (e.g. doxifluridine, 136 fluorouracil, azacitidine, carmofur) were effective against intracellular S. Tm and bacteria grown 137 in LPM or MOPS minimal media, but not MHB. As genes involved in nucleotide biosynthesis 138 are required for intracellular growth (Figure 1 , e.g. pyrC, pryE, pyrF, purE, purF, purG), these 139 data suggest that our genetic and chemical screens accurately probed the intramacrophage 140 environment encountered by S. Tm. Our analysis identified 31 compounds that were exclusively 141 active in LPM or macrophages and not in MHB or MOPS. We prioritized 15 of these, based on 142 low host cell cytotoxicity, potency, chemical diversity and commercial availability. 143
Our work thus far utilized a luminescence-based readout for bacterial viability and an 144 immortalized macrophage cell line. We tested the 15 priority actives for the ability to reduce 145 intracellular replication (measured by CFU enumeration) of S. Tm in primary bone marrow-146 derived macrophages isolated from C57BL/6 mice ( Figure 3A ). Ciprofloxacin is an antibiotic 147 routinely used in salmonellosis infection treatment and was therefore included for comparison. 148
Of the compounds tested, 11 significantly reduced bacterial replication within 4 hours at a 149 concentration of 128 µg/mL (P <0.05, two-way ANOVA, Bonferroni multiple test correction). 150 We prioritized those which reduced bacterial viability >2-fold at a concentration of 64 µg/mL or 151 less: bromperidol, metergoline, rifampicin, ciclopirox, furazolidone, and ethopropazine. 152
Rifampicin and furazolidone are known antibiotics and therefore were not investigated further. 153
The four remaining compounds had increased activity in LPM relative to MHB ( Figure 3B ), 154
suggesting selectivity of these antimicrobials for an in vivo-mimicking environment. We 155 6 measured the impact of these four compounds on bacterial replication in the presence of 156 bafilomycin, an inhibitor of vacuolar ATPase activity that blocks acidification of the SCV. 157
Remarkably, bafilomycin pretreatment of bone marrow-derived macrophages antagonized the 158 activity of bromperidol, metergoline, and ethopropazine administered at 8 µg/mL ( Figure 3C ), 159
suggesting that their antimicrobial efficacy was dependent on the acidic intracellular 160 environment. Taken together, our data suggest that these compounds work in concert with one or 161 more components of the intracellular environment. Metergoline was the most potent of these 162 compounds and was the focus of subsequent studies of mechanism and in vivo efficacy. 163 164
The Gram-negative outer membrane antagonizes metergoline activity 165 Metergoline significantly reduced S. Tm growth within primary macrophages at 8 µg/mL.
166
The MIC of metergoline against S. Tm grown in MHB is above its solubility limit (~256 167 µg/mL), although its MIC in LPM is 128 µg/mL. The discordance in metergoline potency 168 against bacteria grown in MHB, LPM, or within macrophages led us to hypothesize that 169 intracellular bacteria were hypersensitized to metergoline as a result of a unique mechanism-of-170 action (MOA). To gain insight into the antibacterial activity of metergoline, we first used the 171 SGD collection to investigate its genetic interactions. We grew this collection of S. Tm deletion 172 mutants in the presence of a sub-lethal concentration of metergoline (100 µg/mL) and compared 173 the growth of each mutant to an MHB control ( Figure 4A and Supplementary Dataset S5). These 174 data revealed that deletions of genes involved in assembly of LPS (rfaG, rfaQ), outer membrane 175 (OM) integrity (asmA, tolQ, tolR, yfgL), turnover of cell wall (ldcA, prc, nlpI), or RND efflux 176 pumps (tolC, acrB) are required for normal growth in the presence of metergoline. We observed 177 that deletions of tolC, tolR, and rfaQ in S. Tm all resulted in hypersensitivity to metergoline in 178 the intracellular environment ( Figure S2A ). From this, we inferred that: (i) disruption of OM or 179 cell wall integrity increases metergoline potency, and (ii) metergoline is a substrate of the 180
AcrAB-TolC efflux pump. Indeed, RfaG and RfaQ are both required for synthesis of the inner 181 core of LPS, Prc and NlpI are both components of a periplasmic protease complex important for 182 peptidoglycan recycling, TolQ and TolR are components of the Tol-Pal complex required for  183 OM integrity, and AcrB and TolC are inner-and outer-membrane components of the major 184 multi-drug efflux pump in Enterobactericeae. 185
Given the hypersensitivity of OM mutants to metergoline, we reasoned that OM-186 perturbing agents might potentiate its activity. In line with this, we noted that in our chemical 187 screens, several antibiotics conventionally active against only Gram-positive bacteria (rifampin, 188 rifamixin, mupirocin, novobiocin) inhibited growth of S. Tm in LPM and/or macrophages. These 189
antibiotics are known to be potentiated against Gram-negative bacteria in the presence of OM 190 perturbing agents (e.g. colistin 27 and pentamidine 28 ), leading us to speculate that acidic (LPM) or 191 intracellular (macrophage) environments compromise the OM of S. Tm. Indeed, uptake of the 192 hydrophobic dye N-phenyl-1-naphthylamine (NPN) was enhanced >5-fold when S. Tm was 193 grown in LPM ( Figure S2B ), a result consistent with increased OM permeability 29 . As predicted, 194
we found that metergoline synergized with several OM-perturbing agents, including EDTA, 195 polymyxin B, and polymyxin B nonapeptide, and was also potentiated in an efflux-deficient 196 strain ( Figure 4B and Figure S2C and metergoline in LPM, but also enhances the synergy in MHB ( Figure S2C ). Additionally, 204
PhoP did not have a major impact on LPM-dependent permeabilization of the OM as determined 205 by NPN uptake ( Figure S2B ). 206 We hypothesized that metergoline may be more active against Gram-positive bacteria, 207 which do not possess an OM barrier. As expected, metergoline was >8-fold more potent against 208 methicillin-resistant Staphylococcus aureus (MRSA) than S. Tm in MHB ( Figure S2D ), and 209 approximately equipotent against both bacteria in primary macrophages ( Figure 3A and Figure  210 S2E). Surprisingly, metergoline still synergized with polymyxin B against MRSA. In addition to 211 OM disruption, polymyxin B can disrupt the cytoplasmic membrane of both Gram-negative and 212
Gram-positive bacteria, and the latter activity is enhanced by the inner membrane activity of 213 bicarbonate 31 . Indeed, bicarbonate increased the potency of metergoline against MRSA and 214 dramatically enhanced the synergy with polymyxin B in both MRSA and S. Tm ( Figure 4B and 215 Figure S2D ). 216
The above data strongly suggested that the activity of metergoline against intracellular S. 217
Tm is in large part due to pH-dependent permeabilization of the OM. We therefore used atomic 218 force microscopy (AFM) to examine the surface topology of intracellular S. Tm. We quantified 219 surface roughness of S. Tm recently isolated from primary bone marrow-derived macrophages 220 (see Materials and Methods) and compared this to S. Tm grown in LPM or MHB 221
(Supplementary Dataset S6). We observed almost a 50% increase in average surface roughness 222 for intracellular S. Tm relative to those grown in MHB, and close to a 250% increase in surface 223 roughness for bacteria grown in LPM ( Figure 4C and Figure S3 ). Remarkably, S. Tm isolated 224 from macrophages treated with bafilomycin displayed a largely uniform surface topology 225 comparable to cells grown in MHB. This provides direct evidence that the acidic intracellular 226 environment alters the OM of S. Tm and offers a compelling explanation for the increased 227 potency of metergoline against macrophage-internalized bacteria compared to cells cultured in 228 standard lab media. When considered with our chemical-genetic interaction data demonstrating 229 the importance of cell envelope homeostasis in macrophages ( Figure 1 ), and the potentiation of 230
conventionally Gram-positive targeting antibiotics we observed in our chemical screens 231 (Supplementary Dataset S3), these results suggest that membrane perturbation of intracellular S. 232
Tm potentiates molecules that may otherwise be incapable of traversing the Gram-negative OM. 233 234
Metergoline disrupts the inner membrane and reduces cellular energy pools 235
As noted above, both active efflux and the OM permeability barrier contribute to the poor 236 activity of metergoline against S. Tm grown in MHB. Thus, disruption of OM integrity is 237 required for metergoline activity. Sensitivity to metergoline can be induced in vitro through 238 genetic disruption of efflux (i.e. a ∆tolC strain). Indeed, we discovered that metergoline is 239 bacteriolytic against a ∆tolC strain of S. Tm ( Figure 4D ). In this strain, we were unable to isolate 240 spontaneous resistance mutants after several attempts plating at 4xMIC (observed frequency of 241 resistance <4.8 x 10 -10 ). Recently, it has been proposed that antibiotic-induced bacterial cell 242 death can be partially attributed to an imbalance in proton homeostasis across the inner 243 membrane 32,33 . Moreover, previous work suggested that the antifungal activity of metergoline 244
against Candida krusei was due to depolarization of the mitochondrial membrane potential and 245 induction of reactive oxygen species 34 . Lastly, inner-membrane active bicarbonate 31 increased 246 the potency of metergoline against both OM-perturbed S. Tm and MRSA ( Figure 4B and Figure  247 8 S2C). Together, these observations led us to hypothesize that metergoline influences membrane 248 potential in S. Tm. In Gram-negative bacteria, the inner cytoplasmic membrane maintains the 249 proton motive force (PMF) at a constant value to generate energy that is necessary for ATP 250 synthesis by the F1-F0 ATPase 35 . The PMF is composed of electrical potential (Δψ) and a 251 transmembrane proton gradient (ΔpH), and perturbations to either component result in precise 252 compensatory increases to the other 36 . This process may be targeted by membrane potential-253 uncoupling antibiotics, wherein the dissipation of either Δψ or ΔpH results in a collapse of the 254 PMF 31,37,38 . Remarkably, we discovered that metergoline caused a rapid release of 3,3'-255 dipropylthiadicarbocyanine iodide (DiSC3(5)) ( Figure 4E ), a fluorescent probe that accumulates 256 in the inner membrane in a Δψ-dependent manner 39 . Disruption of Δψ results in a release of the 257 DiSC3(5) dye and increased fluorescence; thus, our results suggested that metergoline treatment 258 impacts electrical potential in S. Tm. 259
The impact of metergoline on the PMF of the inner membrane suggested that it might 260 modulate cellular ATP levels. Indeed, we found that cellular ATP levels were reduced ~10-fold 261 after a 30 min exposure to 128 µg/mL metergoline ( Figure 4F ). By comparison, the well-known 262 protonophore carbonyl cyanide m-chlorophenyl hydrazone (CCCP) at a concentration of 32 263 µg/mL led to a <2-fold in ATP levels in the same time frame ( Figure S4A ). CCCP selectively 264
targets ΔpH 40 , and we observed striking synergy between metergoline and CCCP, supporting an 265 inner membrane-specific role for metergoline ( Figure S4B ). We observed a similar effect of 266 metergoline on DiSC3(5) release in MRSA ( Figure S4C ), as well as synergy between three 267 distinct PMF-dissipating molecules with metergoline ( Figure S4D ). 268 269
Chemical structure-activity-relationship identifies two metergoline analogues with 270 antibacterial activity 271
Having examined the bacterial determinants for metergoline efficacy, we wanted to 272 explore the chemical properties of the metergoline scaffold required for activity. We therefore 273 tested sixteen structurally related analogs for the ability to reduce growth of wildtype and ∆tolC 274 S. Tm in MHB, LPM, and macrophages, as well as MRSA grown in MHB (Table S2 ). Four of 275 the analogs evaluated herein were FDA-approved therapeutics that contain the core ergot 276 alkaloid scaffold but diverge structurally from metergoline in multiple regions ( Figure 5 ). These 277 compounds: nicergoline (2), pergolide (3), cabergoline (4), and methysergide (5), are neuroactive 278 drugs that interact with dopamine and/or serotonin receptors, similar to metergoline (1). The 279 remaining twelve analogs were synthesized from metergoline by systematic replacement of the 280 benzyl carbonate moiety with other groups (Figure 5 , compounds 6-17).
281
Of the four ergot-based drugs, nicergoline (2) showed modest antimicrobial efficacy 282 while the remaining compounds (3-5) were inactive in our assays (Table S2 ). Given that the 283
activity of metergoline appears to be enhanced in the low pH environments of LPM and 284 macrophages, we considered the possibility that metergoline may be acting as a pro-drug by 285 means of hydrolysis of the acid-labile carbamate moiety to release its corresponding amine 6. 286
Evaluation of compound 6, however, showed no in vitro efficacy at 128 ug/mL in all but one 287 assay (in MHB supplemented with EDTA) and inferior intra-macrophage growth inhibition 288
relative to metergoline (0.39 growth vs. control). The remaining synthetic analogs consisted of: 289 acetamide 7, alkyl carboamates 8 and 9, amide derivatives 10-14, benzyl urea derivative 15, 290
sulfonamide 16, and amine 17 ( Figure 5 ). Most of these analogs were inactive in our assays but 291 compounds 13 and 16 demonstrated antimicrobial activity comparable to metergoline. In vitro, 292 the α,β-unsaturated amide 13 was twice as potent as metergoline while the phenethyl 293 9 sulfonamide 16 had approximately half of the potency of metergoline. Both 13 and 16 also 294 inhibited intra-macrophage growth of S. Tm with similar potency to metergoline. These 295 compounds were more toxic to macrophages (18.07 and 19.86 % toxicity) relative to metergoline 296
(2.9 % toxicity) as determined by lactate dehydrogenase release (Table S2) . 297 298
Metergoline reduces bacterial load in a murine model of S. Tm systemic infection 299
Given its potency in vitro, we tested the efficacy of metergoline against a systemic 300 murine infection with S. Tm. Mice intraperitoneally infected with S. Tm develop symptoms 301 consistent with typhoid fever and typically succumb within 72 hours. Metergoline is a naturally 302 occurring alkaloid compound derived from ergot fungus, and, to our knowledge, its in vivo 303 efficacy has been explored solely in experiments to characterize its anxiolytic effects in mice as a 304
5HT (serotonin) antagonist [41] [42] [43] . We found that metergoline (5 mg/kg) significantly reduced 305 bacterial load in the spleen, liver, cecum, and colon ( Figure 6A ) and significantly extended 306 animal survival time ( Figure 6B ). As expected, one of the amide derivatives (12) which we 307 found to have poor in vitro activity did not reduce bacterial load nor prolong survival. These 308 results demonstrate that metergoline has antibacterial activity against S. Tm in vivo. 309 310
Discussion 311 312
Intracellular pathogens often occupy niches that are difficult to recapitulate in vitro; thus, 313
we and others have developed fluorescence, luminescence, and colorimetric-based screening 314 assays with readouts that approximate bacterial viability over traditional cfu counting methods 44-315 48 . Here we describe a macrophage-based chemical screen specific for intracellular S. Tm, 316
leading to the discovery of metergoline as an antibacterial with in vivo efficacy, and the 317 unexpected identification of outer membrane disruption in the intracellular environment. Further, 318
we show that metergoline disrupts the proton motive force across the S. Tm cytoplasmic 319 membrane, diminishes cellular ATP levels, reduces bacterial load in a murine model of systemic 320
S. Tm infection, and significantly prolongs survival of infected animals. This work highlights the 321 ability for intracellular chemical screens to accurately predict in vivo efficacy, and their potential 322 to yield better leads against intracellular bacteria. Such screens offer the opportunity to directly 323 assess host cell cytotoxicity to select against off-target effects, and better select molecules with 324 favorable pharmacological properties within host cells, which typically represent considerable 325 challenges in the treatment of intracellular infections. 326
Our chemical screen was selective for molecules with antimicrobial efficacy conditional 327 to the intracellular environment. We found that metergoline was inactive in standard growth 328 media at neutral pH and that the acidification-blocking activity of bafilomycin abrogated its 329
activity, suggesting that low pH of LPM and/or the SCV sensitizes S. Tm to othwerwise inactive 330 compounds. Because we were able to recapitulate the antimicrobial activity of metergoline in 331 non-acidic environments by inducing OM perturbation with membrane-permeabilizing agents 332
(EDTA, PMB) or in a ∆tolC mutant background, we sought to characterize OM integrity in S. 333
Tm grown under acidic conditions. Low pH in the intracellular environment is a critical signal 334 for multiple two-component regulatory systems in S. Tm (PhoPQ, PmrAB, SsrAB) 49-51 , such that 335 its detection acts as a cue for virulence gene expression. Given the importance of low pH as a 336 regulatory input governing S. Tm pathogenesis within cells, antibiotics selective for intracellular 337 S. Tm must account for the genetic and physiological profiles of S. Tm grown in acidic 338
conditions. Interestingly, we found that acidified S. Tm undergoes a loss of normal OM surface 339 structure and experiences OM disruption, as quantified by NPN uptake. These data strongly 340
suggest that acidic pH in the intracellular environment perturbs the OM. Our observation that 341
conventionally Gram-positive antibiotics are potentiated in LPM and macrophages provides 342 further evidence for increased OM permeability in acidic environments. Taken together, these 343
findings have important implications for antibiotic drug discovery. Gram-negative bacteria are 344 susceptible to antibiotics capable of directly diffusing through the OM lipid layer (e.g. 345 polymyxins and aminoglycosides) and small hydrophilic antibiotics that traverse the OM through 346 porin channels 52,53 . Overcoming the Gram-negative OM permeability barrier is currently one of 347 the greatest challenges in drug-discovery programs directed at these difficult to treat infections. 348
However, our work indicates that natural components of the innate immune system may sensitize 349
intracellular Gram-negative bacteria to otherwise poorly penetrating antibacterial compounds in 350
vivo. 351
Overall, we propose a model for metergoline's antibacterial activity in vivo wherein this 352
compound is capable of accumulating in the SCV, then targets the cytoplasmic membrane due to 353 pH-dependent permeabilization of the S. Tm OM. It is tempting to speculate that the low pH in 354 the SCV enhances metergoline's activity by altering the relative contributions of membrane 355 potential (Δψ) and pH gradient (∆pH) to the proton motive force, however, further work is 356 required to investigate this. Screening for antimicrobials selective for bacteria within 357 macrophages is able to select for those that target conditionally essential genes, due to the unique 358 conditions of the intracellular environment. Indeed, genes that are essential for growth under 359 conditions that more closely resemble those during infection is a promising avenue in modern 360
antibiotic research that has garnered increased attention in recent years 54 . For complex S. Tm 361 infections that include several bacterial subpopulations with highly varied gene expression and 362 virulence phenotypes, the identification of novel antimicrobials with unique targets is critical. 363 We conclude that intracellular-targeting chemical screening platforms have the potential to 364 identify small molecules with relatively underexplored targets, a goal of paramount importance 365 in the current antibiotic resistance era. 366 367
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The authors declare no competing financial interests. 397 consistency, in the experiments presented in Figure 1 and Figures S1 and S3 , the wildtype S. Tm 497 14028s strain was used for comparison. For compound screening and secondary assays, S. Tm 498 SL1344 was transformed with pGEN-lux 55 , and SL1344 ∆tolC was generated by standard 499 methods 56 . Briefly, the chloramphenicol resistance cassette from pKD3 was amplified by PCR 500 with primers 5'-501 CAATTATTTTTACAAATTGATCAGCGCTAAATACTGCTTCACAACAAGGAGTAGGCT 502
GGAGCTGC-3'and 5'-503 AGACCTACAAGGGCACAGGTCTGATAAGCGCAGCGCCAGCGAATAACTTACATATG 504
AATATCCTCCTTAGTTCC-3' and the resulting amplicon was transformed into electro-505 competent S. Tm SL1344 cells harboring the pSim6 plasmid as previously described 57,58 . 506
Successful recombinants were confirmed by colony PCR using primers 507 5'CGACCATCTCCAGCAGCCAC-3' and 5'GAAAAGGCGAGAATGCGGCG-3'. 508
Experiments with Staphylococcus aureus used a Canadian isolate (CMRSA10) of community-509 acquired methicillin-resistant S. aureus USA300 59 . 510
Overnight cultures of bacteria were inoculated with a single colony and routinely grown 511 in LB media (10 g/L NaCl, 10 g/L Tryptone, 5 g/L yeast extract) supplemented with antibiotics 512 as appropriate (streptomycin, 150 µg/mL; chloramphenicol, 25 µg/mL; kanamycin, 50 µg/mL, 513 ampicillin, 100 µg/mL). Where indicated, bacteria were subcultured 1:100 and grown to mid-log 514 phase in cation-adjusted MHB (BBL TM Mueller Hinton II Broth -Cation Adjusted), LPM (5 515 mM KCl, 7.5 mM (NH4)2SO4, 0.5 mM K2SO4, 10 mM Glucose, 49 µM MgCl2, 337 µM PO4 3-, 516 0.05% casamino acids, 80 mM MES, pH 5.8), or MOPS glucose minimal medium (Teknova)  517 supplemented with 40 µg/mL histidine when growing S. Tm SL1344. Bacteria were grown at 518 37 o C. 519 520
Genetic Screening 521
The Salmonella single-gene deletion (SGD) library 19 was pinned from frozen DMSO stocks at 522 384-colony density onto LB agar medium containing 50 µg/mL kanamycin using a Singer 523
RoToR HDA (Singer Instruments) and grown for 18 h at 37 o C. The SGD was then grown 524 overnight in 384-well clear flat-bottom plates (Corning) in either MOPS glucose ( Figure 1A) or 525 LB ( Figure 4A ) supplemented with 50 µg/mL kanamycin. The Singer RoToR HDA was then 526 used to inoculate assay plates (containing 50 µL/well LPM without casamino acids, MHB, or 527 MHB with 100 µg/mL metergoline) with a starting inoculum of approximately 1.7 x 10 5 528 CFU/well. Optical density at 600 nm (OD600) was measured with a Tecan M1000 Infinite Pro 529 plate reader at the time of inoculation (T0) and after 16 hrs (T16) incubation at 37 o C with shaking 530 at 220 rpm. Growth was calculated by subtracting the pre-reads (T16 -T0) and normalizing for 531 plate and well effects as previously described 60 . The interaction score was calculated by dividing 532 normalized growth in the presence of metergoline by the MHB control. Experiments were 533 performed in duplicate or triplicate as noted. 534 535
Replication of SGD mutants in macrophages 536
Strains from the Salmonella single-gene deletion library were selected based on prioritization 537 from genetic screening in LPM (growth < 3.5σ from mean of screening data), along with SPI-1, 538 SPI-2, virulence, motility, and regulatory genes, and WT to use as controls. macrophages and plates were centrifuged at 500 x g for 2 min followed by a 30 min incubation at 575 37 o C with 5% CO2. Media was then aspirated and replaced with fresh DMEM containing 100 576 µg/mL gentamicin to eliminate extracellular bacteria, and plates were incubated for 30 mins at 577 37 o C with 5% CO2. Infected cells were washed with PBS prior to addition of 100 µL of DMEM 578 containing compound at 10 µM. Luminescence was read immediately after compound addition 579 (To) and plates were then incubated for 3 hr at 37 o C with 5% CO2. Luminescence was measured 580
Statistical analysis 711
Data were analyzed using R or GraphPad Prism 6.0 software (GraphPad Inc., San Diego, CA), 712
with 
